Enhancement of locomotor activity and conditioned reward to cocaine by brain-derived neurotrophic factor

Journal of Neuroscience

Volumn 19, Issue 10, 1999, Pages 4110-4122

  Horger, Brian A ^a,b   Iyasere, Christiana A ^a   Berhow, Melissa T ^a   Messer, Chad J ^a   Nestler, Eric J ^a   Taylor, Jane R ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GENENTECH INC   (United States)

Author keywords

BDNF; Conditioned reward; Mesolimbic dopamine system; Nucleus accumbens; Psychomotor stimulant sensitization; Ventral tegmental area

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; COCAINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; MESOLIMBIC DOPAMINERGIC SYSTEM; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; REINFORCEMENT; VENTRAL TEGMENTUM;

EID: 0033562567     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.19-10-04110.1999     Document Type: Article

References (80)

1. Altar CA, Boylan CB, Jackson C, Hershenson S, Miller G, Wiegand NJ, Lindsay RM, Hyman C (1992) Brain-derived neurotrophic factor augments rotational behavior and nigrostriatal dopamine turnover. Proc Natl Acad Sci USA 89:11347-113551.
2. Altar CA, Boylan CB, Fritsche M, Jackson C, Hyman C, Lindsay RM (1994) The neurotrophins NT-4/5 and BDNF augment serotonin, dopamine and GABAergic systems during behaviorally effective infusions into the substantia nigra. Exp Neurol 130:31-34.
3. Beninger RJ, Hanson DR, Phillips AG (1981) The acquisition of responding with conditioned reinforcement: effects of cocaine, (+)-amphetamine and pipradrol. Br J Pharmacol 74:149-154.
4. Berhow MT, Russell DS, Terwilliger RZ, Beitner-Johnson D, Self DW, Lindsay, RM, Nestler EJ (1995) Influence of neurotrophic factors on morphine- and cocaine-induced biochemical changes in the mesolimbic dopamine system. Neuroscience 4:969-979.
5. Berhow MT, Hiroi N, Nestler EJ (1996) Regulation of ERK (extracellular signal-regulated kinase), part of the neurotrophin signal transduction cascade, in the rat mesolimbic dopamine system by chronic exposure to morphine or cocaine. J Neurosci 16:4704-4715.
6. Bothwell M (1995) Functional interactions of neurotrophins and neurotrophin receptors. Annu Rev Neurosci 18:223-253.
7. Bozarth MA, Wise RA (1986) Involvement of the ventral tegmental dopamine system in opioid and psychomotor stimulant reinforcement. In: Problems in drug dependence (Harris LS, ed), pp 190-196. Washington, DC: US Government Printing Office.
8. Burns LH, Everitt BJ, Robbins TW (1994) Intra-amygdala infusion of the N-methyl-D-aspartate receptor antagonist AP5 impairs acquisition but not performance of a discriminated approach to an appetitive CS. Behav Neural Biol 61:242-250.
9. Cador M, Taylor JR, Robbins TW (1991) Potentiation of the effects of reward-related stimuli by dopaminergic-dependent mechanisms in the nucleus accumbens. Psychopharmacology 104:377-385.
10. Childress AR, McLellan AT, Ehrman R, O'Brien CP (1988) Classically conditioned responses in opioid and cocaine dependence: a role in relapse? Natl Inst Drug Abuse Res Monogr 84:25-43.
11. Childress AR, Ehrman R, Rohsenow DJ, Robbins SJ, O'Brien CP (1992) Classically conditioned factors in drug dependence. In: Substance abuse: a comprehensive textbook, Ed 2 (Lowinson JW, Luiz P, Millman RB, Langard JG, eds), pp 56-69. Baltimore: Williams and Wilkins.
12. Chu B, Kelley AE (1992) Potentiation of reward related responding by psychostimulant infusion into nucleus accumbens: role of dopamine receptor subtypes. Psychobiology 153-162.
13. Cunningham ST, Kelley AE (1992) Evidence for opiate dependent cross-sensitization in nucleus accumbens: studies of conditioned reward. Brain Res Bull 29:675-680.
14. Cunningham ST, Kelley AE (1993) Hyperactivity and sensitization to psychostimulants following cholera toxin infusion into the nucleus accumbens. J Neurosci 13:2342-2350.
15. Davis WM, Smith SG (1974) Behavioral control exerted by an amphetamine based conditioned reinforcer. In: Neurobiology and influences on behavior, Vol 3, Drug addiction (Singh JM, Lal H, eds), pp 209-217. New York: Stratton.
16. de Wit H, Stewart J (1981) Reinstatement of cocaine-reinforced responding in the rat. Psychopharmacology 75:134-143.
17. DiStefano PS, Friedman B, Radziejieski AC, Boland P, Schick CM, Lindsay RM, Wiegand SJ (1992) The neurotrophin BDNF, NT-3, and NGF display distinct patterns of retrograde axonal transport in peripheral and central neurons. Neuron 8:983-993.
18. Everitt BJ, Robbins TW (1992) Amygdala-ventral striatal interactions in reward-related processes. In: The amygdala (Aggelton JP, ed), pp 401-409. New York: Wiley.
19. Frank L, Wiegand J, Siuciak JA, Lindsay RM, Rudge JS (1997) Effects of BDNF infusion on the regulation of TrkB protein and message in adult rat brain. Exp Neurol 145:62-70.
20. Hebert MA, Van Horne CG, Hoffer BJ, Gerhardt GA (1996) Functional effects of GDNF in normal rat striatum: presynaptic studies using in vivo electrochemistry and microdialysis. J Pharmacol Exp Ther 279:1181-1190.
21. Hiroi N, Brown JR, Haile CN, Greenberg ME, Nestler EJ (1997) FosB mutant mice: loss of chronic cocaine induction of Fos-related proteins and heightened sensitivity to cocaine's psychomotor and rewarding effects. Proc Natl Acad Sci USA 94:10397-10402.
22. Horger BA, Taylor JR, Elsworth JD, Roth RH (1994) Preexposure to, but not co-treatment with, the neurotensin antagonist SR 48692 delays the development of cocaine sensitization. Neuropsychopharmacology 11:215-222.
23. Horger BA, Nishimura MC, Armanini MP, Wang L-C, Poulsen KT, Rosenblad C, Kirik D, Moffat B, Simmons L, Johnson Jr E, Milbrandt J, Rosenthal A, Björklund A, Vandlen RA, Hynes MA, Phillips HS (1998) Neurturin exerts potent actions on survival and function of midbrain dopaminergic neurons. J Neurosci 18:4929-4937.
24. + toxicity: role of BDNF gene expression. Mol Brain Res 41:16-26.
25. Hyman C, Hofer M, Barde Y-A, Jahasz M, Yancopoulos GD, Squinto SP, Lindsay RM (1991) BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 350:230-232.
26. Ip NY, Ibanez CF, Nye SH, McClain J, Jones PF, Gies DR, Bellusco L, Lebeau MM, Espinosa R III, Squinto SP, Perssen H, Yancopoulos GD (1992) Mammalian neurotropin-4: structure, chromosomal localization, tissue distribution and receptor specificity. Proc Natl Acad Sci USA 89:3060-3064.
27. Javoy-Agid F, Taquet H, Ploska H, Cherif-Zahar C, Ruberg M, Agid Y (1981) Distribution of catecholamines in the ventral mesencephalon of human brain, with special reference to Parkinson's disease. J Neurosci 36:2101-2105.
28. Kalivas PW (1993) Neurotransmitter regulation of dopamine neurons in the ventral tegmental area. Brain Res Rev 18:75-113.
29. Kalivas PW, Duffy P (1993) Time course of extracellular dopamine and behavioral sensitization to cocaine. I. Dopamine axon terminals. J Neurosci 13:266-275.
30. Kalivas PW, Stewart J (1991) Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization. Brain Res Rev 16:223-244.
31. Kalivas PW, Sorg BA, Hooks MS (1993) The pharmacology and neural circuitry of sensitization to psychostimulants. Behav Pharmacol 4:315-334.
32. Kaplan DR, Hempstead BL, Martin-Zanca D, Chao MV, Parada LF (1991) The trk proto-oncogene product: a signal transducing receptor for nerve growth factor. Science 252:554-558.
33. Kawamoto Y, Nakamura S, Nakano S, Oka N, Akiguchi I, Kimura J (1996) Immunohistochemical localization of brain-derived neurotrophic factor in adult rat brain. Neuroscience 74:1209-1226.
34. Kelley AE, Delfs JM (1991a) Dopamine and conditioned reinforcement. I. Differential effects of amphetamine microinjections into striatal subregions. Psychopharmacology 103:187-196.
35. Kelley AE, Delfs JM (1991b) Dopamine and conditioned reinforcement. II. Contrasting effects of amphetamine microinjections into the nucleus accumbens with peptide microinjections into the ventral tegmental area. Psychopharmacology 103:197-203.
36. Kelley AE, Holahan MR (1997) Enhanced reward-related responding following cholera toxin infusion into the nucleus accumbens. Synapse 26:46-54.
37. Koob GF (1992) Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol Sci 13:177-184.
38. Koob GF, Le Moal M (1997) Drug abuse: hedonic homeostatic dysregulation. Science 278:52-58.
39. Korte M, Carroll P, Wolf E, Brem G, Thoenen H, Bonhoeffer T (1995) Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor. Proc Natl Acad Sci USA 92:8860-8865.
40. Kuhar MJ, Ritz MC, Boja JW (1991) The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci 14:299-302.
41. Lapchak PA, Hefti F (1992) BDNF and NGF treatment in lesioned rats: effect of cholinergic treatment on weight gain. NeuroReport 3:405-408.
42. Liebman JM, Cooper SJ (1989) The neuropharmacological basis of reward (Liebman JM, Cooper SJ, eds). New York: Oxford UP.
43. Lindsay RM, Wiegand SJ, Altar CA, DiStefano PS (1995) Neurotrophic factors: from molecule to man. Trends Neurosci 17:182-189.
44. Loughlin SE, Fallon JH (1993) Neurotrophic factors. New York: Academic.
45. Mackintosh NJ (1974) The psychology of animal learning. London: Academic.
46. Markou A, Weiss F, Gold LH, Caine SB, Schulteis G, Koob GF (1993) Animal models of drug craving. Psychopharmacology 112:163-182.
47. Martin-Iverson MT, Altar CA (1996) Spontaneous behaviors of rats are differentially affected by substantia nigra infusion of brain-derived neurotrophic factor and neurotrophin-3. Eur J Neurosci 8:1696-1706.
48. Martin-Iverson MT, Todd KG, Altar CA (1994) Brain-derived neurotrophic factor and neurotrophin-3 activate striatal dopamine and serotonin metabolism and related behaviors: interactions with amphetamine. J Neurosci 14:1262-1270.
49. Miserendino MJ, Nestler EJ (1995) Behavioral sensitization to cocaine: modulation of the cyclic AMP system in the nucleus accumbens. Brain Res 674:299-306.
50. Mufson EJ, Kroin JS, Sobreviela T, Burke MA, Kordower JH, Penn RD, Miller JA (1994) Intrastriatal infusions of brain-derived neurotrophic factor: retrograde transport and colocalization with dopamine containing substantia nigra neurons in rat. Exp Neurol 129:15-26.
51. Nestler EJ, Aghajanian GK (1997) Molecular and cellular basis of addiction. Science 278:58-63.
52. Nestler EJ, Berhow MT, Brodkin ES (1996) Molecular mechanisms of drug addiction: adaptations in signal transduction pathways. Mol Psychiatry 1:190-199.
53. Numan S, Seroogy KB (1997) Increased expression of trkB mRNA in rat caudate-putamen following 6-OHDA lesions of the nigrostriatal pathway. Eur J Neurosci 9:489-495.
54. O'Brien CP, Childress AR, McLellan T, Ehrman R (1992) A learning model of addiction. In: Addictive states (O'Brien CP, Jaffe JH, eds), pp 157-177. New York: Raven.
55. Paxinos G, Watson C (1982) The rat brain in stereotaxic coordinates. New York: Academic.
56. Paxinos G, Watson C (1997) The rat brain in stereotaxic coordinates. New York: Academic.
57. Pelleymounter MA, Cullen MJ, Wellman CL (1995) Characteristics of BDNF-induced weight loss. Exp Neurol 131:229-238.
58. Phillips GD, Robbins TW, Everitt BJ (1994) Mesoaccumbens dopamine-opiate interactions in the control over behaviour by a conditioned reinforcer. Psychopharmacology 114:345-359.
59. Ranaldi R, Beninger RJ (1995) Bromocriptine enhancement of responding for conditioned reward depends on intact D1 receptor function. Psychopharmacology 118:437-443.
60. Robbins TW (1978) The acquisition of responding with conditioned reinforcement: effects of pipradrol, methylphenidate, d-amphetamine and nomifensine. Psychopharmacology 58:78-87.
61. Robbins TW, Watson BA, Gaskin M, Ennis C (1983) Contrasting interactions of pipradrol, d-amphetamine, cocaine, cocaine analogues, apomorphine and other drugs with conditioned reinforcement. Psychopharmacology 80:113-119.
62. Robbins TW, Cador M, Taylor JR, Everitt BJ (1989) Limbic-striatal interactions in reward-related processes. Neurosci Biobehav Rev 13:155-162.
63. Robinson TE, Berridge KC (1993) The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Rev 18:247-291.
64. Robinson TE, Kolb B (1997) Persistent structural modifications in nucleus accumbens and prefrontal cortex neurons produced by previous experience with amphetamine. J Neurosci 17:8491-8497.
65. Sauer H, Fischer W, Nikkhah G, Wiegand SJ, Brundin P, Lindsay RM, Björklund A (1993) BDNF enhances function rather than survival of intrastriatal dopamine cell-rich grafts. Brain Res 626:37-44.
66. Schmidt-Kastner R, Wetmore C, Olson L (1996) Comparative study of brain-derived neurotrophic factor messenger RNA and protein at the cellular level suggests multiple roles in hippocampus, striatum and cortex. Neuroscience 74:161-183.
67. Seroogy K, Gall C (1993) Expression of neurotrophins by midbrain dopaminergic neurons. Exp Neurol 124:119-128.
68. Shaham Y, Stewart J (1995) Stress reinstates heroin self-administration behavior in drug-free animals: an effect mimicking heroin, not withdrawal. Psychopharmacology 119:334-341.
69. Shen RY, Altar CA, Chiodo LA (1994) Brain-derived neurotrophicfactor increases the electrical activity of pars compacta dopamine neurons in vivo. Proc Natl Acad Sci USA 91:8920-8924.
70. Shults CW, Matthews RT, Altar CA, Langlais PJ (1994) A single intramesencephalic injection of brain-derived neurotrophic factor induces persistent rotational asymmetry in rats. Exp Neurol 124:119-128.
71. Siuciak JA, Boylyn B, Fritsche, Altar CA, Lindsay RM (1996) BDNF increases monoaminergic activity in rat brain following intracerebro-ventricular or intraparenchymal administration. Brain Res 710:11-20.
72. Sklair-Tavron L, Shi W-X, Lane SB, Harris HW, Bunney BS, Nestler EJ (1996) Chronic morphine induces visible changes in the morphology of mesolimbic dopamine neurons. Proc Natl Acad Sci USA 93: 11202-11207.
73. Spina MB, Squinto SP, Miller J, Lindsay RM, Hyman C (1992) Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenyl-pyridinium ion toxicity: involvement of the glutathione system. J Neurochem 59:99-106.
74. Stephens RM, Loeb DM, Copeland TD, Pawson T, Greene LA, Kaplan DR (1994) Trk receptors use redundant signal transduction pathways involving SHC and PLC-γ1 to mediate NGF responses. Neuron 12:691-705.
75. Taylor JR, Horger BA (1999) Enhanced responding for conditioned reward produced by intra-accumbens amphetamine is potentiated after cocaine sensitization. Psychopharmacology 142:31-40.
76. Taylor JR, Robbins TW (1984) Enhanced behavioral control by conditioned reinforcers following microinjections of d-amphetamine into the nucleus accumbens. Psychopharmacology 84:405-412.
77. Taylor JR, Robbins TW (1986) 6-Hydroxydopamine lesions of the nucleus accumbens, but not the caudate nucleus, attenuate enhanced responding with reward-related stimuli produced by intra-accumbens d-amphetamine. Psychopharmacology 90:390-397.
78. Vaidya VA, Siuciak JA, Du F, Duman RS (1999) Mossy fiber sprouting and synaptic reorganization induced by chronic administration of electroconvulsive seizures: role of BDNF. Neuroscience 89:157-166.
79. Winer BJ (1974) Statistical principles in experimental design, Ed 2. New York: McGraw Hill.
80. Wise RA, Bozarth MA (1987) A psychomotor stimulant theory of addiction. Psychol Rev 94:469-492.